Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. (Q51080724)

29 March 2018

title

Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. (English)

1 reference

29 March 2018

author name string

Kehne JH

1

1 reference

29 March 2018

Coverdale S

2

1 reference

29 March 2018

McCloskey TC

3

1 reference

29 March 2018

Hoffman DC

4

1 reference

29 March 2018

Cassella JV

5

1 reference

29 March 2018

publication date

1 June 2000

1 reference

29 March 2018

published in

Neuropharmacology

1 reference

29 March 2018

volume

39

1 reference

29 March 2018

page(s)

1357-1367

1 reference

29 March 2018

issue

8

1 reference

29 March 2018

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

The role of corticotropin-releasing factor in depression and anxiety disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

5-HT1A receptors are not involved in clozapine's lack of cataleptogenic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Roles of the amygdala and bed nucleus of the stria terminalis in fear and anxiety measured with the acoustic startle reflex. Possible relevance to PTSD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Corticotropin-releasing factor receptors: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Distress vocalization in rat pups. A simple screening method for anxiolytic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Multiple regulators of ultrasonic vocalization in the infant rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Desipramine treatment in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Ultrasound vocalization is not related to corticosterone response in isolated rat pups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Antidepressant or antianxiety? A study of the efficacy of antidepressant medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

The pharmacotherapy of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Ultrasonic vocalizations in rat pups: effects of serotonergic ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Paroxetine efficacy in the treatment of generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

Ontogeny of noradrenergic effects on ultrasonic vocalizations in rat pups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900043-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0028-3908(00)00043-5

1 reference

29 March 2018

PubMed ID

10818252

1 reference

29 March 2018